Virology. New vaccine and treatment excite Ebola researchers.
Enserink
Martin
M
D000256:Adenoviridae / Q000235:genetics; D000349:Africa / Q000453:epidemiology; D000818:Animals; D001777:Blood Coagulation; D002986:Clinical Trials as Topic; D004196:Disease Outbreaks; D029043:Ebolavirus / Q000276:immunology*; D005822:Genetic Vectors; D015801:Helminth Proteins / Q000627:therapeutic use; D019142:Hemorrhagic Fever, Ebola / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control; D006801:Humans; D019444:Vaccines, DNA / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology; D014721:Vesicular stomatitis Indiana virus; D014759:Viral Envelope Proteins / Q000235:genetics / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology
D015801:Helminth Proteins; D019444:Vaccines, DNA; D014614:Vaccines, Synthetic; D014759:Viral Envelope Proteins; D014765:Viral Vaccines; C400226:anti-coagulant protein C2, Ancylostoma caninum; C113189:envelope glycoprotein, Ebola virus